Daniel Marechal
Directeur/Bestuurslid bij Targetome NV
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Eric Feller | M | - |
Targetome NV
 Targetome NV Pharmaceuticals: MajorHealth Technology Targetome SA operates is a biotech company which develops affinity-based targeted therapies against unmet medical needs with initial focus on pancreatic cancer and liver metastases. The firm develops antibody-drug conjugates. The company was founded by Edwin de Pauw and Vincent Castronovo in 2010 and is headquartered in Liege, Belgium. | 14 jaar |
| Joseph Martial | M | - |
Targetome NV
Targetome NV Pharmaceuticals: MajorHealth Technology Targetome SA operates is a biotech company which develops affinity-based targeted therapies against unmet medical needs with initial focus on pancreatic cancer and liver metastases. The firm develops antibody-drug conjugates. The company was founded by Edwin de Pauw and Vincent Castronovo in 2010 and is headquartered in Liege, Belgium. | 11 jaar |
| Domenico Petta | M | - |
Targetome NV
Targetome NV Pharmaceuticals: MajorHealth Technology Targetome SA operates is a biotech company which develops affinity-based targeted therapies against unmet medical needs with initial focus on pancreatic cancer and liver metastases. The firm develops antibody-drug conjugates. The company was founded by Edwin de Pauw and Vincent Castronovo in 2010 and is headquartered in Liege, Belgium. | 11 jaar |
| Francesco Fornieri | M | - |
Targetome NV
Targetome NV Pharmaceuticals: MajorHealth Technology Targetome SA operates is a biotech company which develops affinity-based targeted therapies against unmet medical needs with initial focus on pancreatic cancer and liver metastases. The firm develops antibody-drug conjugates. The company was founded by Edwin de Pauw and Vincent Castronovo in 2010 and is headquartered in Liege, Belgium. | 11 jaar |
| John Kelly | M | - |
Targetome NV
Targetome NV Pharmaceuticals: MajorHealth Technology Targetome SA operates is a biotech company which develops affinity-based targeted therapies against unmet medical needs with initial focus on pancreatic cancer and liver metastases. The firm develops antibody-drug conjugates. The company was founded by Edwin de Pauw and Vincent Castronovo in 2010 and is headquartered in Liege, Belgium. | 9 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Denis Hermesse | M | 54 |
University of Liege
| 4 jaar |
| Jean-Marc Gilson | M | 60 |
University of Liege
| 1 jaar |
| François Camille Gilbert van Uffelen | M | - |
University of Liege
| 1 jaar |
| Stephane Berghmans | M | 55 |
University of Liege
| 3 jaar |
| Denis Goffaux | M | 57 |
University of Liege
| 4 jaar |
| Valérie Gordenne | F | 51 |
University of Liege
| 4 jaar |
| Emmanuel Lacroix | M | - |
University of Liege
| 5 jaar |
| Jean-Pierre Verlaine | M | - |
University of Liege
| 2 jaar |
| Philippe Kolh | M | - |
University of Liege
| 4 jaar |
| Nikkolaos Antimissaris | M | 55 |
University of Liege
| 4 jaar |
| Valérie Renard | M | - |
University of Liege
| 4 jaar |
| Dimitri Liquet | M | - |
University of Liege
| 5 jaar |
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| België | 17 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Daniel Marechal
- Persoonlijk netwerk
